Abstract
The hemagglutination inhibition (HI) assay for influenza A virus has been used since the 1940s. The assay may be utilized to detect or quantify antibodies to influenza A viruses and can be used to characterize differences in antigenic reactivity between influenza isolates. In addition, data from HI assays are routinely used for antigenic cartography, influenza virus surveillance, epidemiology, and vaccine-seed strain selection. For antibody quantification, the HI assay is a fast and inexpensive method; other than a source of red blood cells, no expensive or unusual lab equipment is needed, and results can be obtained within a few hours. Historically, the HI assay has also served as a primary method of subtype identification and is still used widely. However, as gene sequencing technology has evolved to be cheaper and faster, it is replacing the HI assay for this purpose.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McClelland L, Hare R (1941) The adsorption of influenza virus by red cells and a new in vitro method of measuring antibodies for influenza virus. Can Public Health J 32(10):530–538
Young GA Jr, Underdahl NR (1950) Neutralization and hemagglutination inhibition of swine influenza virus by serum from suckling swine and by milk from their dams. J Immunol 65(4):369–373
Cohen A, Biddle F (1963) Hemagglutination inhibition: interaction of influenza viruses with horse serum inhibitor. Nature 198:508–509
OIE (2018) Manual of diagnostic tests and vaccines for terrestrial animals 2018. World Organization for Animal Health (OIE). http://www.oie.int/standard-setting/terrestrial-manual/access-online/. Accessed 20 Sept 2018
Anderson TC, Crawford PC, Katz JM, Dubovi EJ, Landolt G, Gibbs EP (2012) Diagnostic performance of the canine influenza A virus subtype H3N8 hemagglutination inhibition assay. J Vet Diagn Investig 24(3):499–508. https://doi.org/10.1177/1040638712440992
Zacour M, Ward BJ, Brewer A, Tang P, Boivin G, Li Y, Warhuus M, McNeil SA, LeBlanc JJ, Hatchette TF, Public Health Agency of C, Canadian Institutes of Health Influenza Research N (2016) Standardization of hemagglutination inhibition assay for influenza serology allows for high reproducibility between laboratories. Clin Vaccine Immunol 23(3):236–242. https://doi.org/10.1128/CVI.00613-15
Wikramaratna PS, Rambaut A (2015) Relationship between haemagglutination inhibition titre and immunity to influenza in ferrets. Vaccine 33(41):5380–5385. https://doi.org/10.1016/j.vaccine.2015.08.065
Stephenson I, Das RG, Wood JM, Katz JM (2007) Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine 25(20):4056–4063. https://doi.org/10.1016/j.vaccine.2007.02.039
Stephenson I, Heath A, Major D, Newman RW, Hoschler K, Junzi W, Katz JM, Weir JP, Zambon MC, Wood JM (2009) Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 15(8):1252–1259. https://doi.org/10.3201/eid1508.081754
Wood JM, Gaines-Das RE, Taylor J, Chakraverty P (1994) Comparison of influenza serological techniques by international collaborative study. Vaccine 12(2):167–174
Abdelwhab EM, Grund C, Aly MM, Beer M, Harder TC, Hafez HM (2016) Benefits and limits of egg yolk vs. serum samples for avian influenza virus serosurveillance. Avian Dis 60(2):496–499. https://doi.org/10.1637/11207-060115-ResNote
Kumar M, Chu HJ, Rodenberg J, Krauss S, Webster RG (2007) Association of serologic and protective responses of avian influenza vaccines in chickens. Avian Dis 51(1 Suppl):481–483
Swayne DE, Suarez DL, Spackman E, Jadhao S, Dauphin G, Kim-Torchetti M, McGrane J, Weaver J, Daniels P, Wong F, Selleck P, Wiyono A, Indriani R, Yupiana Y, Sawitri Siregar E, Prajitno T, Smith D, Fouchier R (2015) Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia. J Virol 89(7):3746–3762. https://doi.org/10.1128/JVI.00025-15
Tian G, Zeng X, Li Y, Shi J, Chen H (2010) Protective efficacy of the H5 inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam. Avian Dis 54(1 Suppl):287–289
Commission E (2006) Commission decision 2006/437/EC of 4 August 2006 approving a diagnostic manual for avian influenza as provided for council directive 2005/94/EC. Off J Eur Union 237
UN OIE (2012) Manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees). http://www.oie.int/manual-of-diagnostic-tests-and-vaccines-for-terrestrial-animals/. Accessed 10 Jan 2019
Comin A, Toft N, Stegeman A, Klinkenberg D, Marangon S (2013) Serological diagnosis of avian influenza in poultry: is the haemagglutination inhibition test really the ‘gold standard’? Influenza Other Respir Viruses 7(3):257–264. https://doi.org/10.1111/j.1750-2659.2012.00391.x
Truelove S, Zhu H, Lessler J, Riley S, Read JM, Wang S, Kwok KO, Guan Y, Jiang CQ, Cummings DA (2016) A comparison of hemagglutination inhibition and neutralization assays for characterizing immunity to seasonal influenza A. Influenza Other Respir Viruses 10(6):518–524. https://doi.org/10.1111/irv.12408
Shiraishi R, Nishiguchi A, Tsukamoto K, Muramatsu M (2012) Comparison of commercial enzyme-linked immunosorbent assay kits with agar gel precipitation and hemagglutination-inhibition tests for detecting antibodies to avian influenza viruses. J Vet Med Sci 74(9):1217–1220
Prince HE, Leber AL (2003) Comparison of complement fixation and hemagglutination inhibition assays for detecting antibody responses following influenza virus vaccination. Clin Diagn Lab Immunol 10(3):481–482
Arnold ME, Slomka MJ, Breed AC, Hjulsager CK, Pritz-Verschuren S, Venema-Kemper S, Bouwstra RJ, Trebbien R, Zohari S, Ceeraz V, Larsen LE, Manvell RJ, Koch G, Brown IH (2018) Evaluation of ELISA and haemagglutination inhibition as screening tests in serosurveillance for H5/H7 avian influenza in commercial chicken flocks. Epidemiol Infect 146(3):306–313. https://doi.org/10.1017/S0950268817002898
Swayne DE, Suarez DL, Sims LD (2013) Influenza. In: Swayne D (ed) Diseases of poultry, 13th edn. Blackwell, Ames, IA, pp 181–218
Wood JM, Major D, Heath A, Newman RW, Hoschler K, Stephenson I, Clark T, Katz JM, Zambon MC (2012) Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine 30(2):210–217. https://doi.org/10.1016/j.vaccine.2011.11.019
Wagner R, Gopfert C, Hammann J, Neumann B, Wood J, Newman R, Wallis C, Alex N, Pfleiderer M (2012) Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach. Vaccine 30(27):4113–4122. https://doi.org/10.1016/j.vaccine.2012.02.077
Noah DL, Hill H, Hines D, White EL, Wolff MC (2009) Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure. Clin Vaccine Immunol 16(4):558–566. https://doi.org/10.1128/CVI.00368-08
Morrison BJ, Martin NJ, Rehman T, Ewing D, Dewar RL, Metcalf J, Sun P, Beigel J, Luke TC, Raviprakash K (2018) Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays. BMC Health Serv Res 18(1):651. https://doi.org/10.1186/s12913-018-3465-3
Wilson G, Ye Z, Xie H, Vahl S, Dawson E, Rowlen K (2017) Automated interpretation of influenza hemagglutination inhibition (HAI) assays: Is plate tilting necessary? PLoS One 12(6):e0179939. https://doi.org/10.1371/journal.pone.0179939
Ananthanarayan R, Paniker CK (1960) Non-specific inhibitors of influenza viruses in normal sera. Bull World Health Organ 22:409–419
Jordan WS Jr, Oseasohn RO (1954) The use of RDE to improve the sensitivity of the hemagglutination-inhibition test for the serologic diagnosis of influenza. J Immunol 72(3):229–235
Cai Z, Zhang T, Wan XF (2010) A computational framework for influenza antigenic cartography. PLoS Comput Biol 6(10):e1000949. https://doi.org/10.1371/journal.pcbi.1000949
Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus ADME, Fouchier RAM (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 1097211
Sitaras I, Kalthoff D, Beer M, Peeters B, de Jong MC (2014) Immune escape mutants of highly pathogenic avian influenza H5N1 selected using polyclonal sera: identification of key amino acids in the HA protein. PLoS One 9(2):e84628. https://doi.org/10.1371/journal.pone.0084628
Sitaras I, Duijzer M, Peeters B, de Jong MCM (2019) Influence of inter-animal variability of HI titres on antigenic cartography in the study of avian influenza viruses: towards making a better map. Vaccine Submitted Manuscript
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
About this protocol
Cite this protocol
Spackman, E., Sitaras, I. (2020). Hemagglutination Inhibition Assay. In: Spackman, E. (eds) Animal Influenza Virus. Methods in Molecular Biology, vol 2123. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0346-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0346-8_2
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0345-1
Online ISBN: 978-1-0716-0346-8
eBook Packages: Springer Protocols